Medical Simulation Market by Product & Service (Model-based Simulation, Web-based simulation, and Simulation Training Services), Fidelity (Low-fidelity, Medium-fidelity, and High-Fidelity), and End User (Academic Institutes and Research Centers, Hospitals & Clinics, and Military Organizations): Global Opportunity Analysis and Industry Forecast, 2018–2025
|
LI_182598
|
Pages: 216
|
Jun
2019 |
6771 Views
|
|
|
|
Author(s) :
Sagar Mukhekar, Kavita Joshi
, Onkar Sumant
|
Tables: 105
|
Charts: 49
|
Formats*:
|
|
Medical Simulation Market Outlook - 2025
The global medical simulation market size was valued at $1,132 million in 2017 and is estimated to reach $3,251 million by 2025, registering a CAGR of 14.0% from 2018 to 2025. Simulation is a generic term that is used for an artificial depiction of a real-world process to achieve educational goals through experiential learning. Simulation-based medical education is defined as any educational activity that utilizes simulation aides to replicate clinical scenarios. Medical simulation is a process of simulating a real-life medical situation to demonstrate and train healthcare professionals. It is considered as the modern-day methodology for training healthcare professionals using advanced educational technology. Medical simulation is also often called as healthcare simulation, simulation in healthcare, and patient simulation.
Get more information on this report : Request Sample Pages
The medical simulation market growth is driven by factors such as growing emphasis on patient safety & outcomes, associated benefits of medical simulation such as illustrating complex and normal cases to professionals and enlightening the medical fraternity about the evolution of medical technology. However, high set-up cost of simulation and other related costs are expected to impede the growth of medical simulation market. In addition, limitation of a complete real situation hampers the growth of medical simulation industry. Conversely, lucrative opportunities in emerging markets is anticipated to create lucrative opportunities for medical simulation market in the near future. Moreover, according to an article published by NCBI, more than 250,000 patients die every year due to medical errors, which makes it the third leading cause of death in the world. The advent of simulation in healthcare has significantly reduced the number of deaths due to unsafe care. Further, the performance of clinicians, especially improving patient safety outcomes, has improved in the recent years with the use of simulation techniques. These factors are expected to boost the growth of the medical simulation market in the near future.
Get more information on this report : Request Sample Pages
Product & Service segment review
Based on medical simulation market analysis, the products and services segment is classified into model-based simulation, web-based simulation, and simulation training services. Model-based simulation segment accounted for the majority of market share in 2017 and is anticipated to remain the same during the forecast period. This is attributed to the benefits offered by model-based simulation over traditional learning, increase in demand for minimally invasive treatments, and rise in focus on patient safety. Moreover, model-based simulation offers numerous advantages including understanding of key concepts & practical information and extensive range of applicability in various fields such as military organizations & academic institutes.
Get more information on this report : Request Sample Pages
Fidelity segment review
The global medical simulation market based on fidelity is segmented into low fidelity, medium fidelity, and high fidelity. Low fidelity simulation (LFS) generated the highest revenue in 2017 and is anticipated to continue the same during the forecast period. This is due to the fact that medical professionals recommend a progressive continuum from low-fidelity simulation (LFS) to high-fidelity simulation (HFS), where early-stage students learn via LFSs with minimal environmental distractions until proficiency of a clinical skill is mastered. However, high fidelity simulation (HFS) segment is anticipated to grow at the fastest rate during the forecast period. High fidelity simulation is a learning method that has proven effective in medical education for technical and non-technical skills. Moreover, high-fidelity simulation (HFS) is a learning technique that involves an imitation of medical scenarios through the use of a computerized manikin that is programed to recreate clinical conditions and to react to learner’s actions in a controlled and safe setting. HFS has been principally investigated in emergency medicine and cardiopulmonary resuscitation and has been recognized as a pivotal learning method for technical and non-technical skills.
Get more information on this report : Request Sample Pages
Region segment review
Based on region, the global medical simulation market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2017, accounting for the highest market share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to the rise in demand for minimally invasive treatments and increase in focus on patient safety. Moreover, technological advancements, established distribution channels, and surge in number of healthcare professionals demanding hands on patient training are the major factors that boost the growth of the medical simulation market in this region. However, as per medical simulation market forecast, Asia-Pacific is projected to register the highest growth rate from 2018 to 2025, owing to the increase in healthcare expenditure, improvements in healthcare infrastructure and rise in medical tourism.
The report provides a comprehensive analysis of the leading companies operating in the global medical simulation market such as 3D Systems Corporation (SIMBIONIX), CAE Inc, Gaumard Scientific Company, Gaumard Scientific Company, Laerdal Medical AS, Limbs and Things LTD., Mentice AB, Simulab Corporation, Simulaids INC., and Surgical Science Sweden AB. . The other players (not profiled in the report) include MSC, 3-Dmed, HRV, Medical Simulation Technologies sp., Remedy Simulation Group, MEDICAL-X, Medaphor, Canadian Aviation Electronics, Ltd., and others.
Key Benefits for Medical Simulation Market:
- The study provides an in-depth analysis medical simulation market share with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided.
- A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
- An extensive analysis of the key segments of the industry helps understand the medical simulation market trends.
- Key players and their strategies are provided to understand the competitive outlook of the industry.
Medical Simulation Key Market Segments:
By Product & Service
- Model-based Simulation
- Patient Simulation
- Task Trainer Simulation
- Manikin-based Simulation
- Standardized Patient Simulation
- Surgical Simulation
- Laparoscopic Surgical Simulators
- Arthroscopic Surgical Simulators
- Cardiovascular Simulators
- Gynecology Simulators
- Others
- Ultrasound Simulation
- Patient Simulation
- Web-based Simulation
- Simulation Software
- Performance Recording Software
- Virtual Tutors
- Simulation Training Services
- Vendor-based Training
- Custom Consulting Services
- Educational Societies
By Fidelity
- Low-fidelity
- Medium-fidelity
- High-fidelity
By End User
- Academic Institutions & Research Centers
- Hospitals & Clinics
- Military Organizations
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Market share analysis, 2018
3.4. Market dynamics
3.4.1. Impact analyses
3.4.2. Drivers
3.4.2.1. Low expenditure on healthcare
3.4.2.2. Assured improvement in patient safety outcomes
3.4.2.3. Benefits of medical simulation
3.4.2.4. Technological advancements in medical field
3.4.3. Restraints
3.4.3.1. High cost of setting up simulators
3.4.3.2. Limitation of a complete real situation
3.4.4. Opportunities
3.4.4.1. Lucrative opportunities in emerging markets
CHAPTER 4: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Model-based simulation
4.2.1. Market size and forecast by type
4.2.1.1. Patient simulation
4.2.1.1.1. Market size and forecast
4.2.1.1.1.1. Task trainer simulation: Market Size and Forecast
4.2.1.1.1.2. Manikin-based simulation: Market Size and Forecast
4.2.1.1.1.3. Standardized Patient Simulation: Market Size and Forecast
4.2.1.2. Surgical simulation
4.2.1.2.1. Market size and forecast
4.2.1.2.1.1. Laparoscopic Surgical Simulators: Market Size and Forecast
4.2.1.2.1.2. Arthroscopic Surgical Simulators: Market Size and Forecast
4.2.1.2.1.3. Cardiovascular Simulators: Market Size and Forecast
4.2.1.2.1.4. Gynecology Simulators: Market Size and Forecast
4.2.1.2.1.5. Others: Market Size and Forecast
4.2.1.3. Ultrasound simulation
4.2.1.3.1. Market size and forecast
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Web-based simulation
4.3.1. Market size and forecast by type
4.3.1.1. Simulation Software: Market Size and Forecast
4.3.1.2. Performance Recording Software: Market Size and Forecast
4.3.1.3. Virtual Tutors: Market Size and Forecast
4.3.2. Market size and forecast by region
4.3.3. Market analysis, by country
4.4. Simulation Training Services
4.4.1. Market size and forecast by type
4.4.1.1. Vendor-based Training: Market Size and Forecast
4.4.1.2. Custom Consulting Services: Market Size and Forecast
4.4.1.3. Educational Societies: Market Size and Forecast
4.4.2. Market size and forecast by region
4.4.3. Market analysis, by country
CHAPTER 5: MEDICAL SIMULATION MARKET, BY FIDELITY
5.1. Overview
5.1.1. Market size and forecast
5.2. Low-fidelity
5.2.1. Market size and forecast by region
5.2.2. Market analysis, by country
5.3. Medium-fidelity
5.3.1. Market size and forecast by region
5.3.2. Market analysis, by country
5.4. High-fidelity
5.4.1. Market size and forecast by region
5.4.2. Market analysis, by country
CHAPTER 6: MEDICAL SIMULATION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Academic Institutions & Research Centers
6.2.1. Market size and forecast by region
6.2.2. Market analysis, by country
6.2.2.1. Medical Academia: Market Size and Forecast
6.2.2.2. Nursing: Market Size and Forecast
6.2.2.3. Emergency Medical Services: Market Size and Forecast
6.3. Hospitals & Clinics
6.3.1. Market size and forecast by region
6.3.2. Market analysis, by country
6.4. Military Organizations
6.4.1. Market size and forecast by region
6.4.2. Market analysis, by country
CHAPTER 7: MEDICAL SIMULATION, BY REGION
7.1. Market size and forecast
7.2. North America
7.2.1. North America: Market Size and Forecast, by country
7.2.1.1. U.S. medical simulation: Market Size and Forecast
7.2.1.1.1. U.S. medical simulation: market size and forecast by product & service
7.2.1.1.2. U.S. medical simulation: market size and forecast by fidelity
7.2.1.1.3. U.S. medical simulation: market size and forecast by end user
7.2.1.2. Canada medical simulation: Market Size and Forecast
7.2.1.2.1. Canada medical simulation: market size and forecast by product & service
7.2.1.2.2. Canada medical simulation: market size and forecast by fidelity
7.2.1.2.3. Canada medical simulation: market size and forecast by end user
7.2.1.3. Mexico medical simulation: Market Size and Forecast
7.2.1.3.1. Mexico medical simulation: market size and forecast by product & service
7.2.1.3.2. Mexico medical simulation: market size and forecast by fidelity
7.2.1.3.3. Mexico medical simulation: market size and forecast by end user
7.2.2. North America: market size and forecast by product & service
7.2.3. North America: market size and forecast by fidelity
7.2.4. North America: market size and forecast by end user
7.3. Europe
7.3.1. Europe: Market Size and Forecast, by country
7.3.1.1. Germany medical simulation: Market Size and Forecast
7.3.1.1.1. Germany medical simulation: market size and forecast by product & service
7.3.1.1.2. Germany medical simulation: market size and forecast by fidelity
7.3.1.1.3. Germany medical simulation: market size and forecast by end user
7.3.1.2. France medical simulation: Market Size and Forecast
7.3.1.2.1. France medical simulation: market size and forecast by product & service
7.3.1.2.2. France medical simulation: market size and forecast by fidelity
7.3.1.2.3. France medical simulation: market size and forecast by end user
7.3.1.3. UK medical simulation: Market Size and Forecast
7.3.1.3.1. UK medical simulation: market size and forecast by product & service
7.3.1.3.2. UK medical simulation: market size and forecast by fidelity
7.3.1.3.3. UK medical simulation: market size and forecast by end user
7.3.1.4. Italy medical simulation: Market Size and Forecast
7.3.1.4.1. Italy medical simulation: market size and forecast by product & service
7.3.1.4.2. Italy medical simulation: market size and forecast by fidelity
7.3.1.4.3. Italy medical simulation: market size and forecast by end user
7.3.1.5. Spain medical simulation: Market Size and Forecast
7.3.1.5.1. Spain medical simulation: market size and forecast by product & service
7.3.1.5.2. Spain medical simulation: market size and forecast by fidelity
7.3.1.5.3. Spain medical simulation: market size and forecast by end user
7.3.1.6. Rest of Europe medical simulation: Market Size and Forecast
7.3.1.6.1. Rest of Europe medical simulation: market size and forecast by product & service
7.3.1.6.2. Rest of Europe medical simulation: market size and forecast by fidelity
7.3.1.6.3. Rest of Europe medical simulation: market size and forecast by end user
7.3.2. Europe: market size and forecast by product & service
7.3.3. Europe: market size and forecast by fidelity
7.3.4. Europe: market size and forecast by end user
7.4. Asia-pacific
7.4.1. Asia-pacific: Market Size and Forecast, by country
7.4.1.1. Japan medical simulation: Market Size and Forecast
7.4.1.1.1. Japan medical simulation: market size and forecast by product & service
7.4.1.1.2. Japan medical simulation: market size and forecast by fidelity
7.4.1.1.3. Japan medical simulation: market size and forecast by end user
7.4.1.2. China medical simulation: Market Size and Forecast
7.4.1.2.1. China medical simulation: market size and forecast by product & service
7.4.1.2.2. China medical simulation: market size and forecast by fidelity
7.4.1.2.3. China medical simulation: market size and forecast by end user
7.4.1.3. India medical simulation: Market Size and Forecast
7.4.1.3.1. India medical simulation: market size and forecast by product & service
7.4.1.3.2. India medical simulation: market size and forecast by fidelity
7.4.1.3.3. India medical simulation: market size and forecast by end user
7.4.1.4. Australia medical simulation: Market Size and Forecast
7.4.1.4.1. Australia medical simulation: market size and forecast by product & service
7.4.1.4.2. Australia medical simulation: market size and forecast by fidelity
7.4.1.4.3. Australia medical simulation: market size and forecast by end user
7.4.1.5. Rest of Asia-pacific medical simulation: Market Size and Forecast
7.4.1.5.1. Rest of Asia-pacific medical simulation: market size and forecast by product & service
7.4.1.5.2. Rest of Asia-pacific medical simulation: market size and forecast by fidelity
7.4.1.5.3. Rest of Asia-pacific medical simulation: market size and forecast by end user
7.4.2. Asia-pacific: market size and forecast by product & service
7.4.3. Asia-pacific: market size and forecast by fidelity
7.4.4. Asia-pacific: market size and forecast by end user
7.5. LAMEA
7.5.1. LAMEA: Market Size and Forecast, by country
7.5.1.1. Brazil medical simulation: Market Size and Forecast
7.5.1.1.1. Brazil medical simulation: market size and forecast by product & service
7.5.1.1.2. Brazil medical simulation: market size and forecast by fidelity
7.5.1.1.3. Brazil medical simulation: market size and forecast by end user
7.5.1.2. South Africa medical simulation: Market Size and Forecast
7.5.1.2.1. South Africa medical simulation: market size and forecast by product & service
7.5.1.2.2. South Africa medical simulation: market size and forecast by fidelity
7.5.1.2.3. South Africa medical simulation: market size and forecast by end user
7.5.1.3. Saudi Arabia medical simulation: Market Size and Forecast
7.5.1.3.1. Saudi Arabia medical simulation: market size and forecast by product & service
7.5.1.3.2. Saudi Arabia medical simulation: market size and forecast by fidelity
7.5.1.3.3. Saudi Arabia medical simulation: market size and forecast by end user
7.5.1.4. Rest of LAMEA medical simulation: Market Size and Forecast
7.5.1.4.1. Rest of LAMEA medical simulation: market size and forecast by product & service
7.5.1.4.2. Rest of LAMEA medical simulation: market size and forecast by fidelity
7.5.1.4.3. Rest of LAMEA medical simulation: market size and forecast by end user
7.5.2. LAMEA: market size and forecast by product & service
7.5.3. LAMEA: market size and forecast by fidelity
7.5.4. LAMEA: market size and forecast by end user
CHAPTER 8: COMPANY PROFILES
8.1. 3D SYSTEMS CORPORATION (SIMBIONIX)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business performance
8.1.4. Key strategic moves and developments
8.2. CAE INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.3. GAUMARD SCIENTIFIC COMPANY
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Key strategic moves and developments
8.4. KYOTO KAGAKU CO. LTD.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.5. LAERDAL MEDICAL AS
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Key strategic moves and developments
8.6. LIMBS AND THINGS LTD.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. MENTICE AB
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Key strategic moves and developments
8.8. SIMULAB CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.9. SIMULAIDS INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Key strategic moves and developments
8.10. SURGICAL SCIENCE SWEDEN AB
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Business performance
8.10.4. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 02. GLOBAL MODEL-BASED SIMULATION MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 03. GLOBAL PATIENT SIMULATION MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 04. GLOBAL SURGICAL SIMULATION MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 05. GLOBAL MODEL-BASED MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 06. GLOBAL WEB-BASED MEDICAL SIMULATION MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 07. WEB-BASED MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 08. GLOBAL SIMULATION TRAINING SERVICES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 09. SIMULATION TRAINING SERVICES MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 10. GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 11. LOW-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 12. MEDIUM-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 13. HIGH-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 14. GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 15. MEDICAL SIMULATION MARKET REVENUE FOR ACADEMIC INSTITUTIONS & RESEARCH CENTERS, BY REGION, 2017–2025 ($MILLION)
TABLE 16. MEDICAL SIMULATION MARKET REVENUE FOR HOSPITALS & CLINICS, BY REGION, 2017–2025 ($MILLION)
TABLE 17. MEDICAL SIMULATION MARKET REVENUE FOR MILITARY ORGANIZATIONS, BY REGION, 2017–2025 ($MILLION)
TABLE 18. MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 19. NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 20. U.S. MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 21. U.S. MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 22. U.S. MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 23. CANADA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 24. CANADA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 25. CANADA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 26. MEXICO MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 27. MEXICO MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 28. MEXICO MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 29. NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 30. NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 31. NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 32. EUROPE MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 33. GERMANY MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 34. GERMANY MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 35. GERMANY MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 36. FRANCE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 37. FRANCE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 38. FRANCE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 39. UK MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 40. UK MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 41. UK MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 42. ITALY MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 43. ITALY MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 44. ITALY MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 45. SPAIN MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 46. SPAIN MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 47. SPAIN MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 48. REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 49. REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 50. REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 51. EUROPE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 52. EUROPE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 53. EUROPE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 54. ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 55. JAPAN MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 56. JAPAN MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 57. JAPAN MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 58. CHINA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 59. CHINA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 60. CHINA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 61. INDIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 62. INDIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 63. INDIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 64. AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 65. AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 66. AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 70. ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 71. ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 72. ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 73. LAMEA MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 74. BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 75. BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 76. BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 77. SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 78. SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 79. SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 80. SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 81. SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 82. SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 83. REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 84. REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 85. REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 86. LAMEA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)
TABLE 87. LAMEA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)
TABLE 88. LAMEA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 89. 3D SYSTEMS: COMPANY SNAPSHOT
TABLE 90. CAE: COMPANY SNAPSHOT
TABLE 91. CAE: OPERATING SEGMENTS
TABLE 92. GAUMARD: COMPANY SNAPSHOT
TABLE 93. KYOTO KAGAKU: COMPANY SNAPSHOT
TABLE 94. KYOTO KAGAKU: OPERATING SEGMENTS
TABLE 95. LAERDAL: COMPANY SNAPSHOT
TABLE 96. LAERDAL: OPERATING SEGMENTS
TABLE 97. LIMBS & THINGS: COMPANY SNAPSHOT
TABLE 98. LIMBS & THINGS: OPERATING SEGMENTS
TABLE 99. MENTICE: COMPANY SNAPSHOT
TABLE 100. MENTICE: OPERATING SEGMENTS
TABLE 101. SIMULAB: COMPANY SNAPSHOT
TABLE 102. SIMULAB: OPERATING SEGMENTS
TABLE 103. SIMULAIDS: COMPANY SNAPSHOT
TABLE 104. SIMULAIDS: OPERATING SEGMENTS
TABLE 105. SURGICAL SCIENCE: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 01. GLOBAL MEDICAL SIMULATION MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 03. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 04. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. MARKET SHARE ANALYSIS, 2018
FIGURE 07. MARKET SHARE ANALYSIS, BY NORTH AMERICA
FIGURE 08. MARKET SHARE ANALYSIS, BY EUROPE
FIGURE 09. MARKET SHARE ANALYSIS, BY ASIA-PACIFIC
FIGURE 10. MARKET SHARE ANALYSIS, BY LAMEA
FIGURE 11. MARKET SHARE ANALYSIS, BY U.S.
FIGURE 12. MARKET SHARE ANALYSIS, BY CANADA
FIGURE 13. MARKET SHARE ANALYSIS, BY GERMANY
FIGURE 14. MARKET SHARE ANALYSIS, BY UK
FIGURE 15. MARKET SHARE ANALYSIS, BY FRANCE
FIGURE 16. TASK TRAINER SIMULATION MARKET REVENUE, 2017-2025($MILLION)
FIGURE 17. MANIKIN-BASED SIMULATION MARKET REVENUE, 2017-2025($MILLION)
FIGURE 18. STANDARDIZED PATIENT SIMULATION MARKET REVENUE, 2017-2025($MILLION)
FIGURE 19. LAPAROSCOPIC SURGICAL SIMULATORS MARKET REVENUE, 2017-2025($MILLION)
FIGURE 20. ARTHROSCOPIC SURGICAL SIMULATORS MARKET REVENUE, 2017-2025($MILLION)
FIGURE 21. CARDIOVASCULAR SURGICAL SIMULATORS MARKET REVENUE, 2017-2025($MILLION)
FIGURE 22. GYNECOLOGY SURGICAL SIMULATORS MARKET REVENUE, 2017-2025($MILLION)
FIGURE 23. OTHERS SURGICAL SIMULATORS MARKET REVENUE, 2017-2025 ($MILLION)
FIGURE 24. ULTRASOUND SIMULATION MARKET REVENUE, 2017-2025($MILLION)
FIGURE 25. COMPARATIVE ANALYSIS OF MODEL-BASED MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26. SIMULATION SOFTWARE MARKET REVENUE, 2017-2025($MILLION)
FIGURE 27. PERFORMANCE RECORDING SOFTWARE MARKET REVENUE, 2017-2025($MILLION)
FIGURE 28. VIRTUAL TUTORS MARKET REVENUE, 2017-2025 ($MILLION)
FIGURE 29. COMPARATIVE ANALYSIS OF WEB-BASED SIMULATION MARKET REVENUE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 30. VENDOR-BASED TRAINING MARKET REVENUE, 2017-2025 ($MILLION)
FIGURE 31. CUSTOM CONSULTING SERVICES MARKET REVENUE, 2017-2025($MILLION)
FIGURE 32. EDUCATIONAL SOCIETIES MARKET REVENUE, 2017-2025($MILLION)
FIGURE 33. COMPARATIVE ANALYSIS OF SIMULATION TRAINING SERVICES MARKET REVENUE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 34. COMPARATIVE ANALYSIS OF LOW-FIDELITY SIMULATION MARKET REVENUE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 35. COMPARATIVE ANALYSIS OF MEDIUM-FIDELITY SIMULATION MARKET REVENUE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 36. COMPARATIVE ANALYSIS OF HIGH-FIDELITY SIMULATION MARKET REVENUE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 37. COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET REVENUE FOR ACADEMIC INSTITUTIONS & RESEARCH CENTERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 38. MEDICAL ACADMEDIA MARKET REVENUE, 2017-2025 ($MILLION)
FIGURE 39. NURSING MARKET REVENUE, 2017-2025 ($MILLION)
FIGURE 40. NURSING MARKET REVENUE, 2017-2025 ($MILLION)
FIGURE 41. COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET REVENUE FOR HOSPITALS & CLINICS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 42. COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET REVENUE FOR MILITARY ORGANIZATIONS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 43. 3M: NET SALES, 2016–2018 ($MILLION)
FIGURE 44. 3D SYSTEMS: REVENUE SHARE BY PRODUCT & SERVICES, 2018 (%)
FIGURE 45. 3D SYSTEMS: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 46. CAE: NET SALES, 2017–2018 ($MILLION)
FIGURE 47. CAE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. CAE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. SURGICAL SCIENCE: NET SALES, 2014–2016 ($MILLION)
Medical simulation involves training and educating the healthcare professionals by replicating the real-life situations. The adoption of medical simulation is expected to increase in the near future, owing to rise in deaths due to medical errors in healthcare facilities such as hospitals.
The global medical simulation market is expected to witness significant growth, owing to benefits associated with medical simulation such as educating the healthcare professionals about the normal as well as complex medical cases. Moreover, rise in demand for improved patient safety outcomes is also expected to boost the market growth. However, high installation cost restrains the market growth.
Among regions, North America dominates the global medical simulation market, owing to increase in incidence of deaths caused due to medical errors and unsafe care, followed by Europe and Asia-Pacific.
Â
Download Sample
Purchase Full Report of
Medical Simulation Market
- Online Only
-
$3,456$3,041 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,379 - Restricted to one authorized user
- One print only
- Available in Excel
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,296 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$4,838 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$6,297 - Unlimited within company/enterprise
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.